Literature DB >> 18031598

Dual roles of NF-kappaB in cell survival and implications of NF-kappaB inhibitors in neuroprotective therapy.

Zheng-hong Qin1, Lu-yang Tao, Xin Chen.   

Abstract

NF-kappaB is a well-characterized transcription factor with multiple physiological and pathological functions. NF-kappaB plays important roles in the development and maturation of lymphoids, regulation of immune and inflammatory response, and cell death and survival. The influence of NF-kappaB on cell survival could be protective or destructive, depending on types, developmental stages of cells, and pathological conditions. The complexity of NF-kappaB in cell death and survival derives from its multiple roles in regulating the expression of a broad array of genes involved in promoting cell death and survival. The activation of NF-kappaB has been found in many neurological disorders, but its actual roles in pathogenesis are still being debated. Many compounds with neuroprotective actions are strongly associated with the inhibition of NF-kappaB, leading to speculation that blocking the pathological activation of NF-kappaB could offer neuroprotective effects in certain neurodegenerative conditions. This paper reviews the recent developments in understanding the dual roles of NF-kappaB in cell death and survival and explores its possible usefulness in treating neurological diseases. This paper will summarize the genes regulated by NF-kappaB that are involved in cell death and survival to elucidate why NF-kappaB promotes cell survival in some conditions while facilitating cell death in other conditions. This paper will also focus on the effects of various NF-kappaB inhibitors on neuroprotection in certain pathological conditions to speculate if NF-kappaB is a potential target for neuroprotective therapy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18031598     DOI: 10.1111/j.1745-7254.2007.00741.x

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  31 in total

1.  Reducing effect of IL-32α in the development of stroke through blocking of NF-κB, but enhancement of STAT3 pathways.

Authors:  Chul Ju Hwang; Hyung-Mun Yun; Yu Yeon Jung; Dong Hun Lee; Na Young Yoon; Hyun Ok Seo; Jin-Yi Han; Ki-Wan Oh; Dong Young Choi; Sang-Bae Han; Do Young Yoon; Jin Tae Hong
Journal:  Mol Neurobiol       Date:  2014-05-24       Impact factor: 5.590

2.  Microglial CD14 activated by iNOS contributes to neuroinflammation in cerebral ischemia.

Authors:  Mian Zhou; Christie M Wang; Weng-Lang Yang; Ping Wang
Journal:  Brain Res       Date:  2013-02-14       Impact factor: 3.252

3.  Fibroblast Growth Factor 9 Stimulates Neuronal Length Through NF-kB Signaling in Striatal Cell Huntington's Disease Models.

Authors:  Issa Olakunle Yusuf; Hsiu-Mei Chen; Pei-Hsun Cheng; Chih-Yi Chang; Shaw-Jenq Tsai; Jih-Ing Chuang; Chia-Ching Wu; Bu-Miin Huang; H Sunny Sun; Chuan-Mu Chen; Shang-Hsun Yang
Journal:  Mol Neurobiol       Date:  2021-01-09       Impact factor: 5.590

4.  Trans-caryophyllene suppresses hypoxia-induced neuroinflammatory responses by inhibiting NF-κB activation in microglia.

Authors:  Kexin Guo; Xiaojie Mou; Jinsha Huang; Nian Xiong; Hongge Li
Journal:  J Mol Neurosci       Date:  2014-02-04       Impact factor: 3.444

Review 5.  Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.

Authors:  Mythily Srinivasan; Debomoy K Lahiri
Journal:  Expert Opin Ther Targets       Date:  2015-02-04       Impact factor: 6.902

6.  Neuroprotective Effect of Plasminogen Activator Inhibitor-1 Antagonist in the Rat Model of Mild Traumatic Brain Injury.

Authors:  Pınar Kuru Bektaşoğlu; Türkan Koyuncuoğlu; Selin Akbulut; Dilek Akakın; İrem Peker Eyüboğlu; Can Erzik; Meral Yüksel; Hızır Kurtel
Journal:  Inflammation       Date:  2021-08-30       Impact factor: 4.092

7.  Uric Acid Neuroprotection Associated to IL-6/STAT3 Signaling Pathway Activation in Rat Ischemic Stroke.

Authors:  Alicia Aliena-Valero; Sergio Rius-Pérez; Júlia Baixauli-Martín; Germán Torregrosa; Ángel Chamorro; Salvador Pérez; Juan B Salom
Journal:  Mol Neurobiol       Date:  2020-09-22       Impact factor: 5.590

Review 8.  Molecular mechanisms of excitotoxicity and their relevance to pathogenesis of neurodegenerative diseases.

Authors:  Xiao-xia Dong; Yan Wang; Zheng-hong Qin
Journal:  Acta Pharmacol Sin       Date:  2009-04       Impact factor: 6.150

9.  NF-κB inhibitor, NEMO-binding domain peptide attenuates intervertebral disc degeneration.

Authors:  Juliane D Glaeser; Khosrowdad Salehi; Linda E A Kanim; Zachary NaPier; Michael A Kropf; Jason M Cuéllar; Tiffany G Perry; Hyun W Bae; Dmitriy Sheyn
Journal:  Spine J       Date:  2020-05-12       Impact factor: 4.166

10.  Down-regulated expression of microRNA-338-5p contributes to neuropathology in Alzheimer's disease.

Authors:  Qi Qian; Jian Zhang; Fang-Ping He; Wang-Xiao Bao; Ting-Ting Zheng; Dong-Ming Zhou; Hong-Yu Pan; Heng Zhang; Xiao-Qin Zhang; Xiao He; Bing-Gui Sun; Ben-Yan Luo; Chu Chen; Guo-Ping Peng
Journal:  FASEB J       Date:  2018-12-21       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.